pbi rampers , page-7

hi vendor,

i for one certainly take your point, but it does depend on what your trading strategy is. Its quite possible you could be using cash to trade other stocks, but equally you could be making wrong calls on those trades and be no better off. Myself I believe in the PBI technology. I believe in its health and wealth benefits. The sell off has also been on relatively small volume and can probably be attributed to placement holders laying off either their free option or holding oprions and selling ordinaries.

Previously its been hard to grab large parcels of pbi and so my strategy was to accumulate over time based on a belief that PBI will ultimately deliver value on the upside -- I like the product, I have measured the risk and I'm happy with the timeline (particularly sofar as it relates to CGT benefits etc). By accumulating on this weakness I have an average price i am happy with and have aquired a large enough parcel to make the upside very lucrative. Nothing the company has done in the past two months has led me to believe that this startegy is flawed. , they've got a placement away at .31, they've aquired a revenue generating growth business, they have the emphysema device in clinical trials, they are having airway clear evaluated for a commercial deal and not one director or major shareholder has sold a share - in fact they've bought more.

There's no doubt if I'd held off i could have bought stock at a cheaper price, and perhaps even in the volumes i wanted -- but then again none of us have a crystal ball. I trust the strategy here. Bios are still doing it hard (witness SLT's great announcement today that moves their tech forward and hardly a ripple on the SP) but PBI has a lot to look forward to, and very little of it is factored into the current price.

but again, i'm no broker, or even a savvy investor, so everything contained above could be hazardous to your wealth.